Welcome to BioReagent Hub Hotline:19920083827
产品资料来源于品牌方官网 yeasen.com  |  仅供选型参考,规格与库存以官方最新信息为准
品官方资料 · 来源可溯查看原始页面 ›
Vendor Tel:400-6111-883
Product data sheet PD-93077ES
Recombinant Biotinylated Human TL1A Protein,His-Avi Tag Recombinant Biotinylated Human TL1A Protein,His-Avi Tag
Enquiry

Tell us your volume and application; we reply with a quote.

Start enquiry

Recombinant Biotinylated Human TL1A Protein,His-Avi Tag

Scan for product
HEK293表达系统抗体药物靶点蛋白炎症性肠病研究
Product no.93077ES Sizes2 options SourceYeasen · Official
Cat. No. 93077ES25
现货 ¥3,795.00
Qty 1
Enquire now
Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status
93077ES25 25 μg ¥3,795.00 现货 Enquire
93077ES70 200 μg ¥14,695.00 现货 Enquire
Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen
Cat.No93077ES
Specification高纯度、高活性、低内毒素、高批间一致性
Origin翌圣生物科技(上海)股份有限公司
技术平台 HEK293表达系统
应用方法 抗体药物靶点蛋白用于抗TL1A抗体药物筛选与功能评价 炎症性肠病研究研究TL1A/DR3/DcR3信号通路在IBD发病机制中的作用
适用物种种属 人
检测方法 SDS-PAGE ELISA LAL法
生物特性参数 蛋白类型重组蛋白;TNF超家族细胞因子 种属来源人 生物活性描述ELISA: Biotinylated Human TL1A Protein; His-Avi Tag was immobilized at 1 μg/ml (100 μL/well) on streptavidin precoated. Increasing concentrations of Anti-Human TNFSF15(TL1A) hIgG1 Antibody were added. 应用抗体药物靶点研究;炎症性肠病(IBD)相关机制研究 产品别称VEGI TNFSF15
样本类型 重组蛋白
技术参数 纯度> 90% as determined by SDS-PAGE 内毒素水平< 1.0 EU per μg by the LAL method 分子量predicted MW of 22.3 kDa 制剂形式Supplied as a 0.2 μm filtered solution of PBS pH7.4. 活性ELISA: Biotinylated Human TL1A Protein; His-Avi Tag was immobilized at 1 μg/ml (100 μL/well) on streptavidin precoated. Increasing concentrations of Anti-Human TNFSF15(TL1A) hIgG1 Antibody were added. 储存条件-85 ~ -65℃保存,收到货之日起,6个月有效期。避免反复冻融,建议等分分装为一次实验使用量,分装后,-80℃冻存。 表达系统HEK293 标签N-His-Avi Tag 表达序列Leu72-Leu251 蛋白登录号O95150-1 外观Liquid
实验类型 SDS-PAGE纯度检测 ELISA生物活性测定 LAL法内毒素水平检测

Recommended reading

Related products

✉Email 💬Message 👤Member
↑Top